MANE
Veradermics, Inc
NYSE · Healthcare · Biotechnology · US
$106.75
−1.78%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.39x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 3.28x
Liquidity & coverage
- Current ratio
- 70.53x
- Quick ratio
- 70.53x
- Cash ratio
- 70.11x
- Interest coverage
- -193.18x
- EBITDA / interest
- -182.82x
- Working capital
- $813.1M
Cash & dividend
- FCF / debt
- -183.00x
- Cash flow / debt
- -182.94x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026